Israel biotech Pluristem has received orphan drug status from the US Food and Drugs Administration for its stem cell treatment of blood vessels disease.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000676759&fid=1725
US approves Israeli treatment for Buerger’s disease
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.